This prospective, randomized controlled trial explored the feasibility and effi cacy of a group program of mindfulness training, a cognitive-behavioral technique, for women with irritable bowel syndrome (IBS). The technique involves training in intentionally attending to present-moment experience and non-judgmental awareness of body sensations and emotions.
INTRODUCTION
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by symptoms of abdominal discomfort associated with defecation disturbances ( 1 ) . It is experienced by about 10 % of American adults, and is more common in women (14 % women and 8 % men). The syndrome results in significant disability, quality of life impairment, and health-care burden ( 2 -4 ) . Conventional medical care for IBS has primarily focused on diet and lifestyle management, behavioral treatments, and pharmacological agents, particularly antispasmodics ( 5 ) . Newer medications approved for IBS include serotonin type-3 receptor antagonists and chloride channel agonists ( 6 ) . Although pharmacological therapies may temporarily relieve symptoms, they are often costly and may result in negative side effects. A substantial proportion of patients with IBS do not attain adequate relief through conventional medical Mindfulness Training Reduces the Severity of Irritable Bowel Syndrome in Women: Results of a Randomized Controlled Trial approaches ( 5 ) . This has led to efforts to find other methods to improve clinical outcomes for IBS patients.
Psychological interventions such as cognitive-behavioral therapy (CBT) and hypnosis have proven among the most successful treatments for IBS ( 7, 8 ) . Th e 2002 Technical Review on IBS by the American Gastroenterology Association ( 9 ) concluded that psychological treatment oft en helps to reduce both bowel symptoms and psychological symptoms and may be used in treating people with IBS in several situations: when the symptoms are moderate to severe; when they have proven refractory to medical treatment; or when evidence points to stress or psychological factors exacerbating the bowel symptoms. Th e Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome, published by the American College of Gastroenterology Task Force on IBS in 2009 ( 10 ) and based on systematic reviews of empirical evidence for therapies of IBS, asserted that psychological therapies, including cognitive therapy, dynamic psychotherapy, and hypnotherapy, but not relaxation therapy, are more eff ective than usual care in relieving global symptoms of IBS . Th e task force assigned this conclusion a grade of " 1B, " meaning strong recommendation supported by moderate evidence.
Psychological treatments are a logical approach to management of the bowel symptoms of IBS because brain -gut interactions are recognized to have a prominent role in modulating gut function ( 9 ) . Th e brain receives a continuous stream of signals from the body informing it about moment-to-moment gastrointestinal activity and events. It formulates an integrated response to this incoming information and sends messages to the gut to regulate the muscular, vascular, secretory, and immune functions of the gastrointestinal tract ( 11 ) . Th e brain ' s emotional motor system, which includes the amygdala, hypothalamus, and medial prefrontal cortex ( 12 ) , makes adjustment to the brain ' s gut regulation in response to emotions and stress, by means of autonomic nervous system signals to the gastrointestinal tract ' s own enteric nervous system. Th e brain also adjusts its perceptual fi ltering of sensory nerve signals coming from the gastrointestinal tract according to the person ' s cognitive and emotional state ( 11 ) . In these ways, psychological factors can infl uence gut activity and contribute to or exacerbate bowel symptoms, and that deleterious infl uence is likely to be more readily addressed through psychological means rather than through pharmaceutical interventions. Psychological treatments may exert their benefi cial eff ects on IBS symptoms by diminishing maladaptive cognitions, negative emotions, or stress that lead to gut disturbance through the brain -gut connection; or they may act more directly on the brain -gut connection by modifying the brain ' s perception of gut sensations or its infl uence on the gut (e.g., by training IBS patients to adopt diff erent habits in attention to gut sensations or to separate their emotions mentally from their gut symptoms). However, to date the particular mechanisms that underlie the demonstrated therapeutic eff ects of psychological treatments on IBS symptoms remain poorly understood.
Mindfulness meditation is a unique psychological approach that integrates the biopsychosocial relationships manifested in IBS, emphasizing as it does mind -body interactions, the role of selfregulation in human physiology, and the capacity for cognitive restructuring. Th e techniques of mindfulness, introduced 2500 years ago by Shakyamuni Buddha, are traditionally recognized as eff ective for calming the mind and generating both insight and compassion. Th e basic technique involves the intentional selfregulation of attention to present-moment experience, using the breath or other object as the focal point, combined with release of cognitive fi xation on thoughts of past and future. Th rough mindfulness practice, one learns to evoke a non-evaluative state of present-moment awareness ( 13, 14 ) . Research has shown that programs such as mindfulness-based stress reduction that involve training and practice of mindfulness can reduce stress and pain symptoms in chronic functional disorders such as fi bromyalgia and depression ( 15 -19 ) . As pain is a prominent symptom in IBS and stress exacerbates IBS symptoms ( 20 ) , mindfulness-training programs would seem to be a reasonable treatment approach for this condition. To date, there have been no controlled clinical trials of the effi cacy of such programs specifi cally for IBS.
Recent investigations have found that mindfulness meditation induces changes in the activation of neural circuits implicated in interoception (awareness of stimuli originating inside the body ( 21 )) and emotion regulation ( 22, 23 ) , while improving attentional control ( 24 -27 ) . Hence, we theorized that mindfulness training may be uniquely suited to treat the psychological factors associated with IBS, including a heightened perception of pain from intestinal distention ( 28 ) that is correlated with selective attention to gastrointestinal sensations and anxiety about the signifi cance of these sensations ( 29 ) . As a primary technique of mindfulness involves attending to the breath and letting go of thoughts, feelings, and story lines that may enhance pain, evoke stress, and induce catastrophizing about negative events, we theorized that mindfulness may have a salutary eff ect on the experiences and symptoms of those with IBS.
Th e aim of this study was to determine the feasibility of developing a clinical trial comparing the effi cacy of group training in mindfulness with an IBS support group (SG) in reducing IBS symptom severity. Th e study utilized a design that controlled for the eff ects of expectancy of improvement and non-specifi c therapeutic factors such as social interaction and social support. Our primary hypothesis was that compared with those participating in an SG, individuals receiving mindfulness training would demonstrate signifi cantly greater reduction in IBS symptom severity, as measured by the IBS symptom severity scale -IBS-SS ( 30 ) . We also hypothesized that, aft er training, those participating in the mindfulness-training group would show reduced psychological distress and improvements in health-related quality of life, increasing at 3 months as compared with immediately post-intervention, and that improvement in these variables, as well as reductions in IBS symptom severity, would be associated with increases in mindfulness scores.
METHODS

Design and procedure
Th e study design was a randomized controlled parallel-group trial. Figure 1 illustrates the overall design and subject fl ow. Th e 
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Participants
Female patients with IBS under the care of a physician were recruited over a 3-year period from 2006 to 2009 through an existing registry of IBS patients interested in participating in research studies, as well as through physicians ' offi ces, local advertisements, and posted fl yers. All interested participants were screened for eligibility by the project coordinator, with referral to the physician co-investigator for additional screening, if needed, to ascertain eligibility.
Inclusion / exclusion criteria
Inclusion criteria were (i) IBS diagnosis according to Rome II criteria and physician diagnosis; (ii) female; (iii) age 18 -75 years; (iv) ability to understand English; (v) willingness to document bowel symptoms and medication use regularly and complete the assessments; and (vi) willingness to attend eight weekly sessions plus one additional half-day session of either mindfulness training or SG. All subjects were informed that they should continue to receive usual care from their physicians and that no specifi c recommendations for changes in medications for IBS would be made by the research team.
Exclusion criteria were (i) diagnosis of mental illness with psychosis; (ii) a history of inpatient admission for psychiatric disorder within the past 2 years; (iii) a history or current diagnosis of infl ammatory bowel disease or gastrointestinal malignancy; (iv) active liver or pancreatic disease; (v) uncontrolled lactose intolerance; (vi) celiac disease; (vii) a history of abdominal trauma or surgery involving gastrointestinal resection; or (viii) pregnancy.
Randomization and assignment
Upon completion of written consent, baseline interview, and questionnaires, eligible study participants were randomized by a computer program to either the mindfulness group (MG) or IBS SG. Figure 1 illustrates the disposition of participants at all stages of the study. Of the 223 women assessed for eligibility, 97 were found to be eligible, and were enrolled and randomly assigned to one of the two treatment groups. Of the 64 ineligible subjects, 10 did not meet Rome II criteria for IBS, 9 had too few symptoms to participate in our study, 14 had other bowel illness or surgery in addition to IBS, 3 were pregnant or intended to become pregnant, 9 had an excluded medical illness and 12 a psychiatric illness, and 7 had prior experience with meditation. In addition, 62 were unavailable to participate: 32 individuals declined during the screening process, largely due to distance to the study site or the time commitment and 30 were eligible and interested, but unable to schedule participation. Subsequently, 75 subjects (76.5 % ) began treatment aft er randomization -36 in the MG and 39 in the SG. did not meet Rome II criteria for IBS, 9 had too few symptoms to participate in our study, 14 had other bowel illness or surgery in addition to IBS, 3 were pregnant or intended to become pregnant, 9 had excluded medical illness and 12 psychiatric illness, and 7 had prior experience with meditation. In addition, 62 were unavailable to participate: 32 individuals declined to participate during the screening process, largely due to distance to the study site or the time commitment and 30 were eligible and interested, but unable to schedule participation. BSI-18, brief symptom inventory-18; FFMQ, fi ve-facet mindfulness questionnaire; IBS, irritable bowel syndrome; IBS-QOL, irritable bowel syndrome-quality of life; IBS-SS, irritable bowel syndrome severity scale; ITT, intent to treat; VSI, visceral sensitivity index.
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Subjects attended an average of 6.7 out of the 9 intervention sessions held for each group (6.3 sessions for SG and 7.1 for MG; P = 0.09). Of the 75 individuals who started treatment, 9 subjects dropped out of the study before post-treatment data could be obtained (2 from the MG and 7 from the SG). Th e overall attrition rate was 12 % . Study participants were remunerated for completing the assessments and for attending a minimum of six of the nine sessions.
Masking
Study staff members involved in data collection and data management were masked to treatment assignment. Due to the nature of the study interventions, subjects and therapists could not be blinded.
To minimize diff erences in subject expectancy, subjects were not informed about the test hypotheses regarding the predicted superior eff ects of mindfulness training on IBS. Th e experimental interventions were described to subjects only as two psychological interventions -a set of meditation procedures and a SG -both of which have been reported in previous studies to benefi t patients with IBS. To verify that patients assigned to the SG had the same expectation of benefi t as those in the MG, all patients completed a treatment credibility scale ( 31 ) aft er the fi rst treatment session.
Intervention conditions
Subjects continued with their usual medical care throughout the study. Following completion of assessment and random assignment, subjects met for a series of sessions in small groups for their assigned intervention. Th e MG was taught by an experienced mindfulness instructor and the SG was led by a licensed clinical social worker or one of two of his well-trained master ' s students. All group leaders followed an explicit protocol; their compliance with the protocol was monitored through videotaping. No protocol deviations were observed.
Th e intervention for both study arms consisted of eight weekly 2-h sessions plus one half-day retreat. Subjects were asked to keep a daily diary during the intervention, in which they recorded minutes of practice time and any IBS symptoms. Subjects could choose to record diary information either electronically on-line (submitted daily) or on paper (submitted weekly at the meetings or mailed). (Seven of the 75 individuals starting the intervention chose to complete paper diaries.) Mindfulness intervention . Th e mindfulness-based stress and pain management program, used as an intervention for the MG, was taught by trained mindfulness instructors and based on the mindfulness-based stress reduction program developed by Jon KabatZinn and Saki Santorelli at the University of Massachusetts. Th is program has been adapted for a wide range of health conditions ( 32 ) . Th e course used in this study was typical in length and content, with instruction and homework assignments related to the body scan (i.e., focusing attention on diff erent parts of the body sequentially to detect sensations such as muscle tension), sitting and walking meditation, and mindful yoga. Th e basic course was adapted to an IBS population by emphasizing the relevance of mindfulness in coping with IBS-related symptoms and perceptions. For example, participants were instructed to notice any sensations in the abdominal area and distinguish those sensations from thoughts about the sensations. In doing so, the mindfulnesstraining intervention promoted sensory vs. emotional processing of interoceptive signals and counteracted catastrophizing, which is a maladaptive cognitive coping style characterized by ruminative thoughts about the signifi cance of symptoms; catastrophizing has been shown to exacerbate irritable bowel symptoms ( 33, 34 ) . Details of the mindfulness as well as SG protocol have been previously reported by our group ( 35 ) . Homework assigned each week throughout the course included daily mindfulness practices and readings from provided texts: " Full Catastrophe Living " for the MG ( 32 ) and " IBS for Dummies " for both the MG and SG ( 36 ) . SG intervention . We selected a social-support group intervention led by master ' s level social workers to control for expectations of benefi t and amount of group contact. A previous study successfully used an SG as a control condition for CBT ( 37 ) . In that study, while the SG produced an expectation of benefi t comparable with the CBT group, there was less change in IBS symptoms than in the CBT group.
As in the mindfulness intervention, the SG included one halfday session during the second half of the 8-week intervention. Th e half-day session involved the preparation and sharing of an " IBS-friendly " meal by the group participants. Weekly sessions, facilitated by social-work group leaders, focused on specifi c predesignated topics and involved open group discussions about subjects ' experiences with, or reaction to, the topic. Please see our previous report for complete details of the SG protocol ( 35 ) . Weekly homework assignments included readings from the provided text, " IBS for Dummies " ( 36 ) .
Measures
Administration of outcome and process measures took place upon entry into the study, at the completion of the 8-week program, and again 3 months aft er program completion. Collection of these data required approximately 1 h. All measures have been described in detail in a previous report ( 35 ) and are presented here only briefl y.
Outcome measures . Th e IBS-SS, a well-validated clinical indicator of illness severity in IBS, served as the primary outcome variable ( 30 ) with the 3-month post-intervention assessment selected a priori as the primary time point to assess effi cacy. Th e IBS-SS has been frequently used in clinical studies. Responders rated retrospectively, for the past 10 days, abdominal pain severity and frequency (separate ratings), bloating severity, dissatisfaction with bowel habits and life interference from bowel symptoms. Th ese fi ve ratings were totaled to obtain an overall IBS severity score with a maximum score of 500. According to the scale developers, a 50-point or greater change on this scale is considered clinically signifi cant ( 30 ) . Secondary outcome variables included (i) the IBS-quality of life (IBS-QOL), a 34-item disease-specifi c quality-of-life scale
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measuring changes in physical and psychosocial functioning as a result of IBS that is responsive to change over 12 weeks ( 38 ) and has been shown to have high internal consistency and high reproducibility ( 39 ); (ii) the visceral sensitivity index, a validated 15-item scale measuring anticipatory anxiety with respect to the likely occurrence of symptoms, ( 40 ) which is a strong predictor of symptom severity ( 40 ) ; and (iii) the brief symptom inventory-18, a validated 18-item short version of the symptom checklist-90-R ( 41 ) with separate subscale scores for anxiety, depression, and somatization, plus a global symptom severity index. (One question, on suicidality, was omitted from the version of the questionnaire used in this study. Full depression and global severity scores were estimated through pro-rating based on the mean for all other items on the same scale.) Process measures . Th e construct of mindfulness was measured by the fi ve-facet mindfulness questionnaire, a 39-item Likerttype scale that assesses fi ve identifi ed facets of mindfulness: nonreactivity to inner experience; a non-judgmental attitude; acting with awareness; describing emotional experience; and observing. Individual facets correlate positively with openness to experience, emotional intelligence, and self-compassion, and negatively with alexethymia, dissociation, and psychological distress ( 42 ) .
Th e Borkovec and Nau ( 43 ) attitude-towards-treatment questionnaire, in the version adapted for IBS ( 44 ) , is a fi ve-item scale (each question off ering a response range from 0 to 9) used to assess patients ' expectations of treatment benefi t and perceptions of the value of the treatment, once treatment has been explained. Subjects completed this scale aft er the fi rst group session. It is standard procedure to apply the Borkovec and Nau instrument aft er the beginning of an intervention to allow participants a brief exposure to the study upon which to base their assessments.
Data analysis
Data were examined to ensure that they were normally distributed and met assumptions for parametric statistical tests. All outcome variables were approximately normally distributed. Bivariate correlations, t -tests, χ 2 tests, and repeated-measures analyses of variance (ANOVA) as implemented in SPSS 17.0 (SPSS, Inc., Chicago, IL), were used to test hypotheses and compare group diff erences at baseline and over time. All group comparisons of changes in outcome variables over time were conducted according to intentto-treat (ITT) methodology, with data from all dropouts included in analyses by carrying forward the last available observation for each subject. No adjustments were made for multiple comparisons. Th e diaries were analyzed for adverse events and diff erences in abdominal pain between the treatment groups (MG vs. SG) during the treatment period.
RESULTS
Pre-treatment group comparisons
Th ere were no signifi cant diff erences between groups in demographic characteristics ( Table 1 ) , although there was a tendency for MG subjects to have a higher level of education and income 
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than SG subjects. Th e average overall IBS severity score before treatment was in the upper end of moderate range on the IBS-SS ( 30 ) and was nearly identical for the two groups.
Treatment credibility
Participants ' rating of the credibility of their assigned treatment was not diff erent between the two groups (mean total scale sums ± s.d. out of a maximum possible score of 45 was 35.03 ± 6.31 for MG vs. 32.69 ± 10.04 for SG; P = 0.26). Subjects in both groups rated their intervention as similarly logical for IBS treatment (6.91 ± 2.15 on a 0 -9 scale for MG vs. 6.28 ± 2.67 for SG; P = 0.29) and reported similar confi dence in their intervention ' s likely success in reducing bowel symptoms (5.94 ± 1.68 on a 0 -9 scale for MG vs. 5.56 ± 2.35 for SG; P = 0.449).
Outcomes
Eff ects on IBS severity -primary end point variable . Th ere was a signifi cant main eff ect of time in the repeated-measures ANOVA. Intent-to-treat analyses of changes in overall IBS severity scores between baseline and post-treatment assessment (F(1, 71) = 20.81, P < 0.0001) and between baseline and 3-month follow-up (F(1, 72) = 21.449, P < 0.0001). A signifi cant intervention × time interaction for IBS severity was also found in both comparisons, indicating that participants in the MG experienced substantially greater improvements in IBS severity compared with baseline than did those in the SG (see Figure 2 ), both at post-treatment evaluation (F(1, 72) = 7.88, P = 0.006) and at 3-month follow-up (F(1, 71) = 11.29, P = 0.001). Main eff ect for group was not significant in either ANOVA. Compared with baseline scores, overall IBS severity was reduced by 26.4 % in the MG vs. 6.2 % in the SG post-treatment and 38.2 % vs. 11.8 % at 3-month follow-up. Th e percentage of subjects who had at least 50-point reduction on the IBS-SS, which is considered clinical signifi cant improvement on this test according to the scale developers ( 30 ) , showed a non-signifi cant trend toward diff erence between MG and SG on MannWhitney U-test both post-treatment (68.8 % vs. 45.2 % , P = 0.06) and at 3-month follow-up (75.0 % vs. 53.1 % ; P = 0.08).
Eff ects on individual IBS-SS symptoms . Individual components of the IBS-SS scale were tested with repeated-measures ANOVA, followed by paired t -tests. Th e results are reported in Table 2 . Abdominal pain severity was signifi cantly more improved in the MG than the SG both immediately aft er treatment and at followup. Improvement in abdominal pain frequency and life interference due to bowel symptoms was not signifi cantly diff erent immediately following the treatment course, but the MG was more improved than the SG on both of those variables at 3-month follow-up, the study ' s primary end point. Among all the ANOVA tests for changes in individual IBS-SS symptoms, main eff ect for group was only signifi cant in the baseline vs. 3-month follow-up comparisons for dissatisfaction with bowel functioning (F(1, 72) = 4.55, P = 0.036) and life interference from bowel symptoms (F(1, 72) = 5.29, P = 0.024).
Post hoc tests comparing baseline to each post-treatment time point showed signifi cant reductions for the MG subjects in all fi ve IBS-SS components both immediately aft er treatment and at follow-up, with the single exception that frequency of abdominal pain (number of days with pain out of the past 10 days) was not signifi cantly reduced at the immediate post-treatment assessment time point. In contrast, the SG subjects did not show a significant reduction on any IBS-SS component at either post-treatment assessment point.
Eff ects of IBS-QOL . Th ere was a signifi cant main eff ect for time in IBS-QOL both between baseline and post-treatment assessment (F(1, 71) = 14.98, P < 0.0001) and baseline and 3-month follow-up (F(1, 71) = 17.94, P < 0.0001) on repeated-measures ANOVAs. Th e intervention × time interaction in IBS-QOL score changes trended toward signifi cance immediately aft er treatment (F(1, 70) = 3.28, P = 0.08), and reached signifi cance at 3-month follow-up (F(1, 71) = 5.12, P = 0.027), indicating that MG participants had experienced signifi cantly greater improvement in IBS-QOL at the latter time point compared with SG participants. Main eff ect for group was not signifi cant in either ANOVA. On post hoc within-group tests, only the MG group was found to have significantly increased IBS-QOL scores post-treatment and at follow-up compared with initial baseline values.
Eff ects on psychological symptoms . Table 3 shows the results of intent-to-treat analyses of changes in psychological symptoms in the two groups. As expected, the MG group improved more at the 3 months, compared with the immediate post-treatment time point. On the brief symptom inventory-18, the degree of improvement from baseline to 3-month follow-up was signifi cantly 
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post-treatment assessment (F(1, 71) = 14.98, P < 0.0001) and between baseline and 3-month follow-up (F(1, 71) = 17.94, P < 0.0001) on repeated-measures ANOVAs. Th e MG showed a signifi cantly greater increase in mindfulness scores than the SG group (i.e., signifi cant time -group interaction on repeatedmeasures ANOVA) at both time points: (F(1, 71) = 4.67, P = 0.03) and (F(1, 69) = 4.27, P = 0.04). Main eff ect for group was not signifi cant on either ANOVA. Only the MG group showed a signifi cant increase in mindfulness aft er treatment on post hoc paired t -tests.
DISCUSSION
Th is study has demonstrated for the fi rst time, using a well-controlled design, that 8 weeks of mindfulness training can reduce IBS symptom severity substantially and produce benefi ts that persist for at least 3 months aft er the intervention. Th e observed therapeutic impact of mindfulness training on IBS severity was clinically signifi cant, as the mean reduction in severity was well above the 50 points recommended as a guideline for clinically diff erent between the two groups for anxiety and general symptom severity scores, and in both of those cases, the MG subjects improved more than the SG subjects. Main eff ect for group was not signifi cant in any of the ANOVA tests of eff ects on psychological symptoms. In post hoc paired t -tests, the SG was not found to be signifi cantly improved in any brief symptom inventory-18 subscale at either post-treatment time point, whereas the MG showed signifi cant improvement on all the scales at 3-month follow-up, as well as on anxiety and general severity at the immediate posttreatment assessment point. At 3-month follow-up, but not immediately aft er treatment, participants in the MG evidenced signifi cantly greater improvements in visceral anxiety compared with the SG (see Table 3 ). Withingroup analyses showed that visceral sensitivity index scores were signifi cantly reduced from baseline at both subsequent time points for the MG subjects, while no signifi cant changes in visceral sensitivity index scores were seen in the SG subjects.
Eff ects on mindfulness . Th ere was a signifi cant main eff ect for time in mindfulness scores both between baseline and 
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signifi cant change on this scale ( 30 ) . On average, MG participants dropped 75 points aft er treatment in their IBS-SS scores, and that drop grew to 108 points by 3 months aft er treatment. In contrast, the SG ' s drop in IBS severity was only 14 and 30 points, respectively, for the same two time points -far below clinical significance -indicating that the treatment outcomes observed for MG participants likely were the result of learning specifi c mindfulness techniques and not merely due to non-specifi c therapeutic factors such as social support and instructor attention. As we expected, the quality-of-life and psychological symptom benefi ts of mindfulness training above the control group developed gradually, manifesting at the trial ' s primary end point, the 3-month followup. Th is, combined with the trend toward continuing improvement in bowel symptoms over time aft er treatment, suggests that mindfulness training may have long-lasting benefi cial eff ects. Additional follow-up and analyses will be conducted to confi rm a continued lasting eff ect of the mindfulness training up to 1 year aft er termination of intervention.
Th is study had a number of notable strengths. Randomization succeeded in producing groups that were well matched at baseline both in IBS severity and quality of life, and comparable in all demographics. We used a credibility scale to establish that the two interventions were perceived as equally credible treatments for IBS symptoms. Hence, diff erences in expectancy for the two interventions are not likely to have played a role in the diff erent outcomes for the groups. Th e conduct of the two interventions was also highly similar in all non-specifi c aspects: both interventions were carried out in a small-group format with the same number and length of sessions and with a similar number of participants per group, and both included an IBS educational book as a part of the intervention package. In addition, we employed a validated process measure to confi rm that the MG intervention led to 
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and facilitating attentional disengagement from gut sensations and obsessive thoughts about visceral function. Our study adds a new and distinctive psychological intervention option to the clinical armamentarium for addressing chronic IBS. Moreover, the intervention tested in our study has the potential advantage of being more cost eff ective than other psychological treatments for IBS, because mindfulness training may be conducted in moderately large groups, whereas the other types of psychological intervention for IBS are more commonly conducted in individual therapy format. Mindfulness-based stress reduction and similar programs, staff ed by well-trained, experienced instructors, can be found at many medical centers throughout the US; physicians referring their patients to these programs can continue to prescribe standard-of-care therapies. Mindfulness training is safe and fully compatible with conventional care approaches and provides patients with greater autonomy in the control of their symptoms.
Th e results of this study raise a number of questions that should be addressed in further research. Th e similarities between the therapeutic eff ects of mindfulness training observed in our trial and in tests of other psychological treatments suggest that common mechanisms are likely responsible for the benefi cial changes. Future research could test for common mediators of change in direct, head-to-head trials of diff erent psychological interventions for this disorder, measuring the diff erential eff ects of various evidence-supported interventions on changes in cognitive -emotional factors, attentional mechanisms, and interoceptive processing of gut-related sensations.
signifi cantly greater increases in dispositional mindfulness, which was the putative therapeutic mechanism, while the SG intervention did not produce a change in mindfulness. We also tested the therapeutic eff ects of mindfulness training 3 months aft er the end of the intervention to confi rm that learning mindfulness likely has lasting, training-specifi c benefi ts. However, 3 months is a relatively short follow-up; future studies should test whether treatment benefi ts are maintained for longer periods such as 1 year or more.
A limitation of this study was that only female IBS patients were included, so the generalizability of the benefi ts of mindfulness training to male IBS patients is unknown. However, exclusion of men was a strategy adopted to minimize heterogeneity in this small-scale trial, and the generalizability is still broad since IBS is twice as common in women as in men. Future trials with larger samples should include male patients.
Although the two intervention groups in this study were not signifi cantly diff erent in any of the measured demographic characteristics, there was a trend for more highly educated and affl uent individuals to be in the MG than the SG (see Table 1 ). To verify that diff erences in socioeconomic group composition did not bias our primary analyses, we re-ran the repeated measurement ANOVAs for our primary end point variable, IBS severity, with these two demographic variables as covariates. Th e results were comparable with those obtained without controlling for the infl uence of these variables, and education and income, therefore, do not seem to bias the fi ndings presented here in Results.
Th is study adds to the growing body of literature on the effi cacy of mindfulness training for other chronic illnesses. Th ere is now evidence to support the therapeutic eff ect of training in mindfulness on a range of stress-related conditions, including type-2 diabetes ( 30, 45 ) , rheumatoid arthritis ( 46, 47 ) , attention-defi cit hyperactivity disorder ( 48 ) , and chronic low back pain ( 49, 50 ) .
At present, a number of other psychological interventions have been found to be helpful in ameliorating the severity of IBS. CBT, clinical hypnosis, and brief dynamic therapy have all been shown to be eff ective in multiple studies ( 7, 8 ) . Like these psychological interventions, mindfulness training leads to substantial improvements in bowel symptoms, as well as quality-of-life and psychological symptoms. Yet, mindfulness is conceptually and procedurally distinct from these other psychological treatments. For example, CBT uses Socratic dialog to restructure catastrophic appraisals of gut sensations, whereas mindfulness training does not attempt to restructure thought content, but instead promotes a non-reactive stance toward gut-related thoughts and feelings. Similarly, while clinical hypnosis employs suggestions and imagery to induce relaxation and alter the perception of visceral sensations, mindfulness training does not attempt to change sensations in the gut as much as foster awareness and acceptance of such sensations. Given these procedural diff erences, mindfulness training for IBS may act through a number of therapeutic mechanisms, including increasing nonreactivity to gut-focused anxieties and catastrophic thoughts about the ability to manage pain; enhancing awareness of IBS symptoms as innocuous interoceptive signals rather than threats to wellbeing; decreasing psychophysiological stress responses;
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
3 Irritable bowel syndrome (IBS) is a common functional bowel disorder causing signifi cant discomfort and impaired quality of life.
